BCL6 inhibitor 7

CAS No. 2097518-46-0

BCL6 inhibitor 7( BCL6-IN-7 | BCL6 IN 7 | BCL6IN7 | BCL6 inhibitor-7 )

Catalog No. M13307 CAS No. 2097518-46-0

A potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 128 In Stock
10MG 227 In Stock
25MG 426 In Stock
50MG 668 In Stock
100MG 977 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BCL6 inhibitor 7
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays.
  • Description
    A potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays (ELISA IC50= 480 nM, M2H IC50= 8.6 uM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BCL6-IN-7 | BCL6 IN 7 | BCL6IN7 | BCL6 inhibitor-7
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bcl-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2097518-46-0
  • Formula Weight
    366.809
  • Molecular Formula
    C18H15ClN6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (13.63 mM)
  • SMILES
    O=C1NC2=C(C=C(NC3=NC(NCC4=CC=CN=C4)=NC=C3Cl)C=C2)C1
  • Chemical Name
    5-((5-Chloro-2-((pyridin-3-ylmethyl)amino)pyrimidin-4-yl)-amino)-1,3-dihydro-2H-indol-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kamada Y, et al. J Med Chem. 2017 May 25;60(10):4358-4368.
molnova catalog
related products
  • MCL-1/BCL-2-IN-2

    MCL-1/BCL-2-IN-2 is a potent and selective dual inhibitor of Bcl-2 and Mcl-1.

  • Mcl-1-Puma inhibitor...

    Mcl-1-Puma inhibitor 8 is a small-molecule dual-acting compound that targets the apoptotic Mcl-1-PUMA interface with Ki of 0.3 uM (Mcl-1, FPA).

  • S55746

    S55746 (BCL201, Servier-1) is a novel potent, selective, orally bioavailable inhibitor of BCL-2 with Ki of 1.3 nM.